The presentation by Associate Professor David Newby on Biological medicines was an excellent overview of how biosimilars are developed and evaluated for their safety and efficacy.
The cost of biologics has been increasing over the past 5 years, the addition of the biosimilar medication will have a significant impact on the PBS. This presentation will assist you in understanding the role of biosimilars in substitution. Please read the presentation attached for more information.
Biosimilars V2.pdf